Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

dc.contributor.author	Großmann, Klaus
dc.date.accessioned	2022-01-17T07:30:37Z
dc.date.available	2022-01-17T07:30:37Z
dc.date.issued	2021
dc.identifier.issn	1422-0067
dc.identifier.uri	http://hdl.handle.net/10900/123024
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/ijms22094805	de_DE
dc.subject.ddc	540	de_DE
dc.subject.ddc	570	de_DE
dc.title	Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210824232002_01409
utue.personen.roh	Grossmann, Klaus
dcterms.isPartOf.ZSTitelID	International Journal of Molecular Sciences	de_DE
dcterms.isPartOf.ZS-Issue	Article 4805	de_DE
dcterms.isPartOf.ZS-Volume	22 (9)	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE